Corbus Pharmaceuticals Holdings, Inc. (CRBP) Operating income 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual operating income history from SEC filings — each fiscal year as reported.
-$85.3MFY2025 · since FY2016: -$20.0M → -$85.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.3M | -75.1% |
| FY2024 | -$48.7M | -8.1% |
| FY2023 | -$45.1M | -13.2% |
| FY2022 | -$39.8M | +28.9% |
| FY2021 | -$56.0M | +54.4% |
| FY2020 | -$122.8M | -59.3% |
| FY2019 | -$77.1M | -35.9% |
| FY2018 | -$56.7M | -74.3% |
| FY2017 | -$32.6M | -62.9% |
| FY2016 | -$20.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBP financial trends
CRBP RevenueCRBP Net incomeCRBP Net marginCRBP Gross profitCRBP Gross marginCRBP Operating marginCRBP Operating cash flowCRBP Free cash flowCRBP Capital expendituresCRBP Return on equityCRBP Stock buybacksCRBP Dividends paidCRBP Total assetsCRBP Total liabilitiesCRBP Shareholders’ equityCRBP overview →